سعر كاتركس شراب 15 مل 0.8% 2025

Egyptian levamisole 0.8% oral syrup (15 ml) by Kahira, an anthelmintic.

• Infections caused by the parasitic worms Ascaris lumbricoides, Necator americanus, Ancylostoma duodenale, Strongyloides stercoralis and Trichostrongylus colubriformis (EU authorisations, now recommended for withdrawal)Population: Adults and childrenEuropean Medicines Agency (EMA)

• Side effects may include abdominal pain, vomiting, headache and dizziness; serious effects may include an increased risk of infection.General active-ingredient information · Wikipedia

• Leukoencephalopathy (damage to brain white matter) is a confirmed rare but serious side effect of levamisole; it can occur after a single dose and symptoms may develop up to several months after treatment. No risk-minimisation measure or risk group was identified, and in February 2026 EMA's PRAC recommended withdrawal of all levamisole medicines from the EU market because benefits no longer outweigh risks.General active-ingredient information · European Medicines Agency (EMA)
• Agranulocytosis (marked loss of white blood cells, mainly neutrophils) is one of the more serious reported side effects.General active-ingredient information · Wikipedia

• Use is not recommended during breastfeeding.General active-ingredient information · Wikipedia

• Levamisole: Stimulates nicotinic acetylcholine receptors of the worm, causing rapid paralysis of worm muscles so that the worm is expelled from the gut.